SNIPR BIOME Announces U.S Food and Drug Administration grants Fast Track Designation for SNIPR001 for Prevention of Bloodstream Infections in Hematologic Cancer Patients
Kevin Outterson’s work is cited.
January 25, 2022 Yahoo! FinanceSNIPR BIOME Announces FDA Clearance of Investigational New Drug (IND) Application for SNIPR001, a Novel CRISPR Therapy Targeting Life-Threatening E. coli Infections
Kevin Outterson’s work is cited.
January 11, 2022 Yahoo! FinanceAntimicrobial Resistance (AMR): What You Need to Know to Keep Yourself and Your Family Safe
Kevin Outterson is featured.
November 22, 2021 HealthyWomenEstimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicine
The centerpiece of the November Health Affairs Journal Club meeting is “Estimating The Appropriate Size Of Global Pull Incentives For Antibacterial Medicines.” In the paper, to appear in the November 2021 issue of the journal, author Kevin Outterson of the Boston University School of Law, examines policy initiatives under way in the US and UK that […]
Pandemic Prevention: How Europe Can Lead the Fight against AMR
The COVID-19 pandemic took the world by surprise. An AMR induced pandemic will not. The World Bank estimates that 10 million people per year could die if new antimicrobials are not found. Without effective prevention and treatment of infections, medical procedures such as organ transplantation, cancer chemotherapy, and major surgery will become too dangerous to […]
In the Calm before the Superbug Storm, the World Needs to Prepare
An opinion authored by Kevin Outterson.
October 15, 2021 STATAntibiotic Resistance: How CARB-X Helps New Companies Get a Running Start
Kevin Outterson is interviewed.
October 13, 2021 The State of Health with Gunnar EsiasonCARB-X Celebrates Fifth Anniversary, $361M Invested into Innovative Therapeutics
Kevin Outterson is quoted.
August 3, 2021 Homeland Preparedness NewsTicking Time Bomb
Kevin Outterson is quoted.
July 29, 2021 ABC NewsThe Next Pandemic is Already Here. Covid Can Teach Us How to Fight It.
Kevin Outterson is quoted.
June 23, 2021 MIT Technology Review